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Abstract 
Microbial foot disorders are quite common around the globe. People who usually don’t take care about their foot 
hygiene and overall health often suffer from serious foot ailments. Causes of these disorders may be poor 
cleanliness, diabetes miletus, improper foot ware and socks use.  Among them, shoes and socks as remain moist 
due to sweat and dirt, are a potent source of microbial invasion which may be either of bacterial, fungal or viral 
origin, sometimes algal too. People of third world countries are more prone to such disorders because of lack of 
awareness. These issues can be controlled by introducing proper general mass awareness regarding foot care and 
hygiene and by spreading information regarding foot ulcers and wounds handling to medical staff and common 
people. 
Keywords: Microbial foot disorders; improper foot ware; microbial invasion; foot hygiene; foot ulcers.  
1. Introduction 
Foot ailments commonly occur due to use of improper and unhygienic socks and shoes. Because people usually 
ignore basic principles of hygiene for feet just like hands [1]. Some may suffer due to such feet microbial 
infections as they are already diabetic or have some wounds or feet ulcers [2]. Some common feet infecting 
microorganisms are of bacterial origin like Pseudomonas aeruginosa, Acinetobacter sp. [3], fungal strains [1], 
often blue green algae [4] and may be some type of enteroviruses [5]. So hygienic care being the essential part 
of life is necessary to maintain good health and prolonged life.  
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Due to the unhygienic condition in third world countries such as Pakistan, India, Afghanistan, Bangladesh and 
other Asians countries may result in many diseases including the foot diseases. Hygienic care is one of the most 
important part in our environment and without it, we cannot live healthy life. The serious health issue such as 
diabetes, eczema and onychomycosis [6] occur due to use of unhygienic and improper shoes and socks. 
Whereas the management of diabetic foot disease is primarily focused on avoiding damaging results of lower 
extremities and it should be sorted out through three main ways; identification of the ―at risk‖ foot, treatment of 
severe foot disease and prevention of further disease problem [7]. Most leading cause of feet ailments is 
microbial infections, in this regard, the dermatophytes are the group of fungi which mainly affect and penetrate 
the keratinized tissue i.e. nails, hairs and skin of human beings and it also affects the animals. It commonly 
causes an infection known as dermatophytosis [8]. Similarly, a most common nail disorder is onychomycosis. In 
North America 7% to 14% people affected by this disease and in Pakistan up to 54% population is suffering 
from it [9, 10, 11, 6]. It is important mention here that severity of shoe and socks diseases increase with the 
passage of time and may result in foot loss [12]. If the infection is not treated accurately and diagnosed at 
earliest then it leads to high level of morbidity and mortality [13]. In this review, authors are trying to highlight 
hygiene-based issues like lack of general public awareness about such feet microbial ailments along with their 
causes, effects and possible control.  
2. Causes & Effects 
There are some factors for development of dermatophytic infections i.e. occlusive footwear, male sex, immune 
system suppression, concurrent dermatological conditions, and moist environment [14]. Potent causes are as 
follows: 
2.1 Lack of hygiene  
Use of mismanufactured or continuously moist like due to sweating and dirty footwear causes which leads to 
fungal infection [15, 16]. Such infections are more common in tropical countries. That’s why; ideal footwear for 
diabetic patients should have a unique style i.e. footwear should have wide toe box, soft soles, extra depth and 
laces for fitting and adjustment. But patient’s compliance about such a footwear is usually poor, particularly at 
home where they are more active than outside [17]. Similarly, tinea pedis does not affect the athletes but also to 
others but comparatively more men are reported than women for this foot ailment because still in major part of 
the world ladies are confined to home and gents are more exposed to external environment and show 
carelessness related to hygienic care. This infection begins from the space between the toes of feet then 
gradually spreads on the foot sole in a ―moccasin‖ pattern [18] and may transform in to foot cancer. Sometimes, 
foot may cut off to prevent the whole leg from spread of infection. Exchange of footwear may cause microbial 
infections by sharing footwear or by contact to others [14]. 
2.2 Bacterial and cyanobacterial infections 
Pitted keratolysis is an infection which is common among athletes and those individuals who use damp and fuzz 
having footwear all time [19]. This skin disorder affects the stratum corneum of the plantar surface. It is caused 
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by the gram- positive bacteria that show coccoid and filamentous morphology [20]. In addition to this, the 
irritative dermatitis due to exposure to skin blue green algae in areas of seashores has been frequently reported 
which is a toxic allergy [21, 22, 4]. Broad spectrum toxicants are found, produced by toxic algae and common in 
tropical regions. The diagnosis and treatment of such dermal ailments of algal origin require the clinical history 
of contact and symptomatic and supportive treatment [4]. Similarly, various aquatic recreational points where 
algal blooms are present may cause dermatitis due to exposure of algal cyanotoxins to humans [23]. Moreover, 
a common moss Bryozoans may cause severe allergic contact dermatitis in fishermen, featuring dry, fissuring 
and exudative lesions of the hands, arms, legs and feet [24]. Addition to this, Calothrix confervicola has been 
found as potent human skin irritant and cause sewed dermatitis or swimmer’s itch [25]. 
2.3 Fungal Allergy & irritation  
Shoe infection may be a form of allergy or due to some irritant contact dermatitis [26]. Reported data suggests 
that skin lesions are often formed due to allergic shoe dermatitis and on exposure of dermal allergens through 
shoes [26-30]. Moreover, these cases are frequently reported in warm areas where overall humidity level and 
sweating rate are higher [26-28]. Similarly, in a heated climate, due to humidity and inner shoe friction, 
sweating, pressure and other chemical reactions which occur inside shoes may cause serious feet infections [26, 
28]. In the recent research, it is noted that leather, rubber and adhesives are the major and most common source 
of shoe allergens [31, 26, 32, 27, 33]. Basically, the use of improper chemicals and components cause shoe 
dermatitis [31, 34]. Different types of shoes in relation to climatic conditions and traditimons may cause diverse 
dermal problems [31, 26, 32, 27]. Similarly, footwear dermatitis is a form of contact dermatitis which is spread 
by shoes and reported data indicates that children are its major sufferers [35]. Moreover, experimental 
investigations high light that shoe dyes and leather may act as allergens i.e. tanning agents are present in 
hypoallergenic shoes leather. 
2.4 Viral infections 
Hand, foot, and mouth diseases are common types of childhood illness caused by enteroviruses. Increasingly, 
the disease has a substantial burden throughout east and southeast Asia [5]. Moreover, diverse viral skin 
biopsies have also been reported on exposed body parts so far [36]. 
2.5 Spoiling wounds and diabetic foot ulcers  
Among microbial feet infections, diabetic foot ulcers are one of the serious complications of diabetes 
progression [6].The three major causes that contributes in this disease are peripheral neuropathy, peripheral 
arterial disease and immunosuppression which may be of microbial origin [37-40]. Some patients of diabetes 
often develop a type of neuropathy which is responsible for the decreased cutaneous sensitivity. Neuropathy 
basically occurs due to the poor nutrition to the nerve endings and as outcome, deficient inflammatory reaction 
due to blockage of influx cause infection [41]. The change in sensitivity causes a severe affect that leads to 
calluses and deformations in feet. These calluses precede the onset of ulcers which are then infected by several 
microorganisms [41]. The infections spread rapidly, in case of poor dermal defense capability. In the diabetic 
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foot, several biochemical abnormalities can induce and accelerate vascular and neuropathological changes in 
patients. One of the most important disease is hyperglycemia. It damages the endothelium of blood vessels and 
stops the production and activation of nitric oxide synthase; it is a crucial element in the mechanism of arterial 
vasodilation. There are many other crucial elements in the genesis of endothelial dysfunction and cell damage 
i.e. Dyslipidemia insulin resistance and oxidative stress [42]. 
2.6 Eczema & other immunological disorders 
Several inflammatory and autoimmune disorders that primarily affect the skin like psoriasis, atopic dermatitis, 
scleroderma, dermatomyositis, cutaneous lupus erythematosus, and generalized vitiligo have been reported so 
far. The way, shoes cause inflammation like eczema on feet due to improper footwear. This eczema may appear 
as bilateral or symmetrical, reciprocal to the depiction of shoe such as uppers and sides, soles, heels and sandal 
straps and no fungal infection are of diverse types of dermal ailments [31, 34, 43-44]. The study of sufferers of 
from foot eczema and leather allergy show that filaggrin mutation is also a major factor which causes the foot 
eczema. There are different forms of eczema i.e., Atopic, Non-atopic. Both are treated in same way so far [45, 
11, 46]. The variations in clinical phenotype of eczema has multiple reasons and although the pathophysiology 
is not completely understood yet. It is known that there is an immune system-based disturbance in skin tissues 
which leads to its damage due to environmental triggers and defective functioning of skin as barrier [45]. 
Common treatments of various types of eczema are moisturizer, thematic steroid, topical inhibitors and UV 
therapy [45, 47]. 
3. Preventive measures 
 
Figure 1: Control of feet microbial infections 
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Following efforts should be adopted for prevention and control of various feet microbial infections (Fig.1). 
3.1 General public awareness 
Preventive measures of disease e.g., Tinea pedis infection include assurance of hygiene, skin should be dry and 
avoid sharing of socks and foot wears with infected individuals [48].  By adopting such precautions and by 
giving a complete awareness to public people about not only diabetic but overall foot care, 49% to 85% of all 
kinds of diabetic foot problems can be avoided [49-51]. Moreover, prevention and management of localized 
trauma or infection and pre-existing vascular damage, improvement regarding poor glycemic control, improved 
awareness and self-practice of foot care are also helpful to minimize the foot ailments [52-53]. 
3.2 Effective remedies 
Some natural ingredients have effective and strong vasodilatory and thrombolytic effects; therefore, it mainly 
takes part in removing the obstruction of small subcutaneous vessels [54-63]. Some of them can even enhance 
angiogenesis [64, 59]. They also prevent damage of mitochondrial material of the endothelial cells by many 
other factors i.e. oxidative stress, subsequent cell death after oxygen glucose deprivation and avoiding damage 
[65]. In nature, there are some natural ingredients that protect the neurons from oxidative stress and decrease the 
ischemic damage by multiple mechanism like inhibiting apoptosis [54, 66-77]. Thus, natural ingredients also 
can decrease local glycemic levels and have a useful antioxidant effects and as result anti-inflammatory 
properties [70]. In the last, some natural ingredients have an antibacterial effect over some bacteria i.e. 
Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa and other bacteria, taking part towards the 
prevention of severe type of diabetic foot infection. They also play important role against fungus. With the 
technology the product remains effective after fifty washes.  
3.3 Cure of diabetic ulcers 
There are many methods to control the diseases for diabetic patients: 
The most important methods are to control the blood glucose and modifiable cardiovascular risk factors such as 
diet, exercise, body weight and cessation of smoking. Foot and footwear should be hygienic based. Education is 
the major point to control the disease for diabetic patients. Education in a structured, organized and repetitive 
manner may prevent foot problem [17]. International Working Group on the Diabetic Foot acknowledges to the 
diabetic patient to control and improve their foot care and hygienic conditions [78]. Wash the feet daily with 
water and dry them carefully, especially between the toes. Use oils or cream for dry skin but not between the 
toes. Cut the nails properly, do not remove skin by chemical agents or plaster, always wear socks with shoes and 
check the shoes before wearing them. Do not walk bare footed all time. After injury or scratches consult with 
doctor immediately [79]. In the whole world nearly 415 million people suffered with diabetes. Out of 415M 
75% people live in low- and middle-income countries. National Institute for Health and Care Excellence gives 
guideline on diabetic foot. They referred three tiers system for foot care and prevention: primary health care for 
preventive services and appropriate referral of diabetic foot; foot protection services at community level for 
management and care of foot problem; and foot care services at tertiary level to handle complex foot problems 
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and diseases. In third world or middle-income countries, doctors are not well trained in a diabetic foot care. 
Multidisciplinary foot care services are available at a few high-level centers and we should train the primary 
doctor about the diabetic foot care. All the hospitals should have to develop the tertiary diabetic foot care 
centers. These centers would provide foot protection, nail care and surgeries in which wound will heal with the 
passage of time. Modern foot services should be provided at all tertiary level hospitals with all facilities. 
4. Conclusion 
Feet microbial infections should not be ignored which are globally overlooked so far due to lack of hygienic 
awareness. That’s why; a person who use frequently leather footwear either with socks or without socks is more 
prone to attack of dermatophytic fungi. Similarly, prevalence of tinea pedis is more in males than females and 
epidemiology of other microbial feet infections is also significant. Moreover, diabetic foot ulcers are associated 
to an increased risk of death, it frequently leads to removal of lower limb. The ways of management that can 
ensure successful and rapid healing of diabetic foot ulcer include education, blood sugar control and surgery. 
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